Nanoviricides (NNVC) Non-Current Assets (2011 - 2026)

Nanoviricides has disclosed Non-Current Assets across 16 years of filings, most recently posting $6.8 million for Q1 2026.

• In Q1 2026, Non-Current Assets fell 6.35% year-over-year to $6.8 million; the TTM figure through Mar 2026 stood at $28.1 million (down 7.53% YoY), while the FY2025 annual figure was $7.2 million, down 8.9% from the prior year.
• Non-Current Assets came in at $6.8 million for Q1 2026 at Nanoviricides, down from $7.0 million in the prior quarter.
• In the past five years, Non-Current Assets ranged from a high of $9.2 million in Q1 2022 to a low of $6.8 million in Q1 2026.
• Average Non-Current Assets over 5 years is $8.0 million, with a median of $7.9 million recorded in 2024.
• Year-over-year, Non-Current Assets decreased 3.49% in 2022 and fell 8.9% in 2025.
• Over 5 years, Non-Current Assets stood at $8.8 million in 2022, then slipped by 7.94% to $8.1 million in 2023, then retreated by 7.24% to $7.5 million in 2024, then decreased by 7.04% to $7.0 million in 2025, then slipped by 1.86% to $6.8 million in 2026.
• Per Business Quant data, the three most recent Non-Current Assets figures were $6.8 million in Q1 2026, $7.0 million in Q4 2025, and $7.1 million in Q3 2025.